Q10 and Aczone drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Q10 (coenzyme q - 10) and Aczone (dapsone). Common drug interactions include renal disorder among females and blood pressure increased among males.
The phase IV clinical study analyzes what interactions people have when they take Q10 and Aczone. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.
What is Q10?
Q10 has active ingredients of coenzyme q - 10. eHealthMe is studying from 34,261 Q10 users. Check the latest studies of Q10.
What is Aczone?
Aczone has active ingredients of dapsone. It is often used in acne. eHealthMe is studying from 1,152 Aczone users. Check the latest studies of Aczone.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
24 people who take Q10 and Aczone together, and have interactions are studied.

What are the common drug interactions of Q10 and Aczone, by gender? *:
female:
- Renal disorder (kidney disease)
- Weight increased
- Cystitis (inflammation of the wall of the bladder)
- Neck pain
- Nocturia (the need to get up in the night to urinate)
- Trigger finger
- Abortion spontaneous (naturally occurring miscarriage)
- Anxiety
- Bladder disorder
- Blood potassium decreased
male:
- Blood pressure increased
- Thyroid cancer
What are the common drug interactions of Q10 and Aczone, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Decreased appetite
- Irritable bowel syndrome
- Mixed connective tissue disease (an autoimmune disease, in which the body's defence system attacks itself)
- Therapeutic response unexpected
- Weight decreased
30-39:
n/a
40-49:
n/a
50-59:
n/a
60+:
- Blood potassium decreased
- Rash
- Type 2 diabetes mellitus
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 41.67%
- Fibromyalgia (a long-term condition which causes pain all over the body): 10 people, 41.67%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 25.00%
- Multiple Myeloma (cancer of the plasma cells): 3 people, 12.50%
- Drowsiness: 2 people, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Q10 and Aczone?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Q10 and Aczone:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Q10:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Aczone:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Q10 and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Aczone and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
- Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
- Semira ZA, Zulfkar Q, Sameem F, "Livedo reticularis associated with dapsone therapy in a patient with chronic urticaria", Indian journal of pharmacology, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on coenzyme q - 10 and dapsone (the active ingredients of Q10 and Aczone, respectively), and Q10 and Aczone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Atenolol and Flecainide Acetate - 4 seconds ago
- Could Cisplatin cause White Blood Cell Count Decreased? - 6 seconds ago
- Could Tylenol cause Alanine Aminotransferase Decreased? - 6 seconds ago
- Drug interactions of Montelukast Sodium and Clonazepam - 6 seconds ago
- Drug interactions of Depo-Medrol and Marcaine - 9 seconds ago
- Could Isentress cause Salmonella Sepsis? - 11 seconds ago
- Could Ozempic cause Rhabdomyolysis? - 13 seconds ago
- Could Magnesium cause Pulmonary Granuloma? - 14 seconds ago
- Could Clonazepam cause Epidermal Necrolysis? - 18 seconds ago
- Could Lopid cause Pharyngolaryngeal Pain? - 21 seconds ago